The Ophthalmologist

Welcome to the Sept/Oct issue of The Ophthalmologist! Our Upfront section features the latest research and trends, covering the impact of smoking on glaucoma, a look at a theranostic “spoonful of sugar,” and more! In our opinion column, Gurpal Virdi and Matt Hirabayashi present an app they have designed to make the IOL selection process easier, and Imran Rahman shares his thoughts on the best way to support community-based healthcare services in the UK. For the December cover feature, The Algorithms of Power, we talk to leaders and pioneers of AI in ophthalmology to break down where we are in the progressive world of machine learning. In this issue’s Cornea and OSD section, 2022 Power Listers give their perspective on the big breakthroughs of the last couple of decades, and Arnaud Lacoste talks about a cell therapy that may change how we treat corneal endothelial dystrophies. In Cataract and Refractive, experts share the names of some of the most accomplished anterior segment specialists, and in Glaucoma, Eva M. del Amo Páez unveils the latest chapter on drug metabolism in the eye. In the Retina section, Michael Volkert explains his gene therapy research that could be used to target oxidative stress and treat retinal degeneration. Finally, we sit down with Michael Mrochen, Founder of IROC Science and serial entrepreneur. I hope you enjoy reading this issue!

Impactful Solutions

October 11, 2022

Sitting Down With… Michael Mrochen, Founder of IROC Science, serial entrepreneur: Co-founder of Vivior AG, Allotex Inc, Overture Ltd, IROC Innocross (Exit) AG, ClearSight Innovation Ltd (Exit)

7 min read